Jump Financial, LLC Veru Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.78 - $15.01 $290,021 - $910,716	60,674 New	60,674 $320,000
Q2 2022 Aug 09, 2022	SELL	$4.35 - $15.85 $4,945 - $18,021	-1,137 Reduced 2.12%	52,560 $594,000
Q1 2022 May 12, 2022	SELL	$4.55 - $6.41 $65,620 - $92,445	-14,422 Reduced 21.17%	53,697 $259,000
Q4 2021 Feb 10, 2022	SELL	$5.89 - $9.73 $71,486 - $118,093	-12,137 Reduced 15.12%	68,119 $401,000
Q3 2021 Nov 12, 2021	SELL	$6.78 - $9.89 $231,496 - $337,684	-34,144 Reduced 29.85%	80,256 $684,000
Q2 2021 Aug 13, 2021	BUY	$7.24 - $11.2 $267,880 - $414,400	37,000 Added 47.8%	114,400 $923,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $623,070 - $1.61 Million	77,400 New	77,400 $834,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.